Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVANTHER: Bevacizumab, Trastuzumab, and Paclitaxel in HER2+ Breast Cancer
NCT01321775Phase 2Unknown
- Sponsor
- HM Sanchinarro
- Start
- Aug 2009
- Primary completion
- Feb 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in breast cancer, sponsored by HM Sanchinarro. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01321775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01321775.